MSI Methylation Sciences Competitors and Similar CompaniesClear all
MSI Methylation Sciences's competitors and similar companies include Stalicla and Supernus Pharmaceuticals.
 MSI Methylation Sciences MSI Methylation Sciences is a biotechnology company focused on the central nervous system (CNS) area. |  Stalicla Stalicla is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. | |
Founding Date | Founding Date 2007 | Founding Date 2017 | Founding Date 2005 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Surrey, CA HQ | Locations Genève, CH HQ | Locations Rockville, US HQ |
Employees | Employees 5 | Employees 264% increase | Employees 6527% increase |
Funding | |||
Latest funding round | Latest funding round $ 30m (over 9 years ago) | Latest funding round $ 8m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 18.2m | Total funding raised $ 69.5m |
For sources of this data, please see the company profile
View Company Profiles
Stalicla
HQ
Genève, CH
Employees
26↑ 4% increase
Stalicla is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.
View companySupernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View company